Listed

Mirum Pharmaceuticals, Inc.

MIRMNasdaqCIK 1759425HealthcareFiscal year ends Dec 31

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Revenue$176.2m, Q2 FY2026
Operating income−$42.5m, Q2 FY2026
Net income−$67.2m, Q2 FY2026
Mirum Pharmaceuticals, Inc., income statement, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Revenue$m47.7Revenue, Q3 FY2023, three months to 2023-09-30$47.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2024-11-12, accession 0001759425-24-000038.Report this figure69.6Revenue, Q4 FY2023, three months to 2023-12-31$69.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-25, accession 0001759425-26-000013. Derived: 12-month figure less the 9-month figure.Report this figure69.2Revenue, Q1 FY2024, three months to 2024-03-31$69.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-05-07, accession 0001759425-25-000032.Report this figure77.9Revenue, Q2 FY2024, three months to 2024-06-30$77.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-08-06, accession 0001759425-25-000041.Report this figure90.4Revenue, Q3 FY2024, three months to 2024-09-30$90.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-04, accession 0001759425-25-000054.Report this figure99.4Revenue, Q4 FY2024, three months to 2024-12-31$99.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-25, accession 0001759425-26-000013. Derived: 12-month figure less the 9-month figure.Report this figure112Revenue, Q1 FY2025, three months to 2025-03-31$111.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-06, accession 0001759425-26-000037.Report this figure128Revenue, Q2 FY2025, three months to 2025-06-30$127.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-05, accession 0001759425-26-000045.Report this figure133Revenue, Q3 FY2025, three months to 2025-09-30$133.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-04, accession 0001759425-25-000054.Report this figure149Revenue, Q4 FY2025, three months to 2025-12-31$148.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-25, accession 0001759425-26-000013. Derived: 12-month figure less the 9-month figure.Report this figure160Revenue, Q1 FY2026, three months to 2026-03-31$159.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-06, accession 0001759425-26-000037.Report this figure176Revenue, Q2 FY2026, three months to 2026-06-30$176.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-05, accession 0001759425-26-000045.Report this figure
Research and development$mnot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Selling, general and administrative$m36.5Selling, general and administrative, Q3 FY2023, three months to 2023-09-30$36.5m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2024-11-12, accession 0001759425-24-000038.Report this figure46.2Selling, general and administrative, Q4 FY2023, three months to 2023-12-31$46.2m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2026-02-25, accession 0001759425-26-000013. Derived: 12-month figure less the 9-month figure.Report this figure45.6Selling, general and administrative, Q1 FY2024, three months to 2024-03-31$45.6m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-05-07, accession 0001759425-25-000032.Report this figure49.2Selling, general and administrative, Q2 FY2024, three months to 2024-06-30$49.2m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-08-06, accession 0001759425-25-000041.Report this figure50.5Selling, general and administrative, Q3 FY2024, three months to 2024-09-30$50.5m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-11-04, accession 0001759425-25-000054.Report this figure56.8Selling, general and administrative, Q4 FY2024, three months to 2024-12-31$56.8m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2026-02-25, accession 0001759425-26-000013. Derived: 12-month figure less the 9-month figure.Report this figure57.7Selling, general and administrative, Q1 FY2025, three months to 2025-03-31$57.7m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-05-06, accession 0001759425-26-000037.Report this figure63.3Selling, general and administrative, Q2 FY2025, three months to 2025-06-30$63.3m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-08-05, accession 0001759425-26-000045.Report this figure61.9Selling, general and administrative, Q3 FY2025, three months to 2025-09-30$61.9m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-11-04, accession 0001759425-25-000054.Report this figure74.1Selling, general and administrative, Q4 FY2025, three months to 2025-12-31$74.1m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2026-02-25, accession 0001759425-26-000013. Derived: 12-month figure less the 9-month figure.Report this figure96.3Selling, general and administrative, Q1 FY2026, three months to 2026-03-31$96.3m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-05-06, accession 0001759425-26-000037.Report this figure81.5Selling, general and administrative, Q2 FY2026, three months to 2026-06-30$81.5m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-08-05, accession 0001759425-26-000045.Report this figure
Operating income$m(25.1)Operating income, Q3 FY2023, three months to 2023-09-30−$25.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2024-11-12, accession 0001759425-24-000038.Report this figure(32.6)Operating income, Q4 FY2023, three months to 2023-12-31−$32.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-25, accession 0001759425-26-000013. Derived: 12-month figure less the 9-month figure.Report this figure(26.5)Operating income, Q1 FY2024, three months to 2024-03-31−$26.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-05-07, accession 0001759425-25-000032.Report this figure(24.2)Operating income, Q2 FY2024, three months to 2024-06-30−$24.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-08-06, accession 0001759425-25-000041.Report this figure(12.7)Operating income, Q3 FY2024, three months to 2024-09-30−$12.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-04, accession 0001759425-25-000054.Report this figure(24.2)Operating income, Q4 FY2024, three months to 2024-12-31−$24.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-25, accession 0001759425-26-000013. Derived: 12-month figure less the 9-month figure.Report this figure(15.2)Operating income, Q1 FY2025, three months to 2025-03-31−$15.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-06, accession 0001759425-26-000037.Report this figure(5.0)Operating income, Q2 FY2025, three months to 2025-06-30−$5.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-05, accession 0001759425-26-000045.Report this figure2.6Operating income, Q3 FY2025, three months to 2025-09-30$2.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-04, accession 0001759425-25-000054.Report this figure(4.6)Operating income, Q4 FY2025, three months to 2025-12-31−$4.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-25, accession 0001759425-26-000013. Derived: 12-month figure less the 9-month figure.Report this figure(789)Operating income, Q1 FY2026, three months to 2026-03-31−$789.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-06, accession 0001759425-26-000037.Report this figure(42.5)Operating income, Q2 FY2026, three months to 2026-06-30−$42.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-05, accession 0001759425-26-000045.Report this figure
Interest expense$m3.6Interest expense, Q3 FY2023, three months to 2023-09-30$3.6m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2024-11-12, accession 0001759425-24-000038.Report this figure3.6Interest expense, Q4 FY2023, three months to 2023-12-31$3.6m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-K filed 2026-02-25, accession 0001759425-26-000013. Derived: 12-month figure less the 9-month figure.Report this figure3.6Interest expense, Q1 FY2024, three months to 2024-03-31$3.6m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2025-05-07, accession 0001759425-25-000032.Report this figure3.6Interest expense, Q2 FY2024, three months to 2024-06-30$3.6m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2025-08-06, accession 0001759425-25-000041.Report this figure3.6Interest expense, Q3 FY2024, three months to 2024-09-30$3.6m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2025-11-04, accession 0001759425-25-000054.Report this figure3.6Interest expense, Q4 FY2024, three months to 2024-12-31$3.6m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-K filed 2026-02-25, accession 0001759425-26-000013. Derived: 12-month figure less the 9-month figure.Report this figure3.6Interest expense, Q1 FY2025, three months to 2025-03-31$3.6m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-05-06, accession 0001759425-26-000037.Report this figure3.6Interest expense, Q2 FY2025, three months to 2025-06-30$3.6m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-08-05, accession 0001759425-26-000045.Report this figure3.6Interest expense, Q3 FY2025, three months to 2025-09-30$3.6m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2025-11-04, accession 0001759425-25-000054.Report this figure3.6Interest expense, Q4 FY2025, three months to 2025-12-31$3.6m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-K filed 2026-02-25, accession 0001759425-26-000013. Derived: 12-month figure less the 9-month figure.Report this figure3.6Interest expense, Q1 FY2026, three months to 2026-03-31$3.6m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-05-06, accession 0001759425-26-000037.Report this figure2.6Interest expense, Q2 FY2026, three months to 2026-06-30$2.6m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-08-05, accession 0001759425-26-000045.Report this figure
Income tax$m0.2Income tax, Q3 FY2023, three months to 2023-09-30$249.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2024-11-12, accession 0001759425-24-000038.Report this figure0.2Income tax, Q4 FY2023, three months to 2023-12-31$225.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-02-25, accession 0001759425-26-000013. Derived: 12-month figure less the 9-month figure.Report this figure0.6Income tax, Q1 FY2024, three months to 2024-03-31$624.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-05-07, accession 0001759425-25-000032.Report this figure0.6Income tax, Q2 FY2024, three months to 2024-06-30$635.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-08-06, accession 0001759425-25-000041.Report this figure0.3Income tax, Q3 FY2024, three months to 2024-09-30$347.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-11-04, accession 0001759425-25-000054.Report this figure(0.6)Income tax, Q4 FY2024, three months to 2024-12-31−$576.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-02-25, accession 0001759425-26-000013. Derived: 12-month figure less the 9-month figure.Report this figure1.0Income tax, Q1 FY2025, three months to 2025-03-31$1.0m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-06, accession 0001759425-26-000037.Report this figure0.4Income tax, Q2 FY2025, three months to 2025-06-30$402.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-05, accession 0001759425-26-000045.Report this figure(0.3)Income tax, Q3 FY2025, three months to 2025-09-30−$262.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-11-04, accession 0001759425-25-000054.Report this figure0.8Income tax, Q4 FY2025, three months to 2025-12-31$767.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-02-25, accession 0001759425-26-000013. Derived: 12-month figure less the 9-month figure.Report this figure0.5Income tax, Q1 FY2026, three months to 2026-03-31$475.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-06, accession 0001759425-26-000037.Report this figure1.7Income tax, Q2 FY2026, three months to 2026-06-30$1.7m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-05, accession 0001759425-26-000045.Report this figure
Net income$m(23.6)Net income, Q3 FY2023, three months to 2023-09-30−$23.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2024-11-12, accession 0001759425-24-000038.Report this figure(35.7)Net income, Q4 FY2023, three months to 2023-12-31−$35.7m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-25, accession 0001759425-26-000013. Derived: 12-month figure less the 9-month figure.Report this figure(25.3)Net income, Q1 FY2024, three months to 2024-03-31−$25.3m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-04, accession 0001759425-25-000054.Report this figure(24.6)Net income, Q2 FY2024, three months to 2024-06-30−$24.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-04, accession 0001759425-25-000054.Report this figure(14.2)Net income, Q3 FY2024, three months to 2024-09-30−$14.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-04, accession 0001759425-25-000054.Report this figure(23.8)Net income, Q4 FY2024, three months to 2024-12-31−$23.8m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-25, accession 0001759425-26-000013. Derived: 12-month figure less the 9-month figure.Report this figure(14.7)Net income, Q1 FY2025, three months to 2025-03-31−$14.7m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-05, accession 0001759425-26-000045.Report this figure(5.9)Net income, Q2 FY2025, three months to 2025-06-30−$5.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-05, accession 0001759425-26-000045.Report this figure2.9Net income, Q3 FY2025, three months to 2025-09-30$2.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-04, accession 0001759425-25-000054.Report this figure(5.7)Net income, Q4 FY2025, three months to 2025-12-31−$5.7m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-25, accession 0001759425-26-000013. Derived: 12-month figure less the 9-month figure.Report this figure(790)Net income, Q1 FY2026, three months to 2026-03-31−$790.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-05, accession 0001759425-26-000045.Report this figure(67.2)Net income, Q2 FY2026, three months to 2026-06-30−$67.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-05, accession 0001759425-26-000045.Report this figure
Diluted EPS$ per share(0.57)Diluted EPS, Q3 FY2023, three months to 2023-09-30−$0.57 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2024-11-12, accession 0001759425-24-000038.Report this figurenot reported(0.54)Diluted EPS, Q1 FY2024, three months to 2024-03-31−$0.54 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-05-07, accession 0001759425-25-000032.Report this figure(0.52)Diluted EPS, Q2 FY2024, three months to 2024-06-30−$0.52 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-08-06, accession 0001759425-25-000041.Report this figure(0.30)Diluted EPS, Q3 FY2024, three months to 2024-09-30−$0.30 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-04, accession 0001759425-25-000054.Report this figurenot reported(0.30)Diluted EPS, Q1 FY2025, three months to 2025-03-31−$0.30 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-06, accession 0001759425-26-000037.Report this figure(0.12)Diluted EPS, Q2 FY2025, three months to 2025-06-30−$0.12 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-05, accession 0001759425-26-000045.Report this figure0.05Diluted EPS, Q3 FY2025, three months to 2025-09-30$0.05 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-04, accession 0001759425-25-000054.Report this figurenot reported(13.43)Diluted EPS, Q1 FY2026, three months to 2026-03-31−$13.43 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-06, accession 0001759425-26-000037.Report this figure(1.06)Diluted EPS, Q2 FY2026, three months to 2026-06-30−$1.06 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-05, accession 0001759425-26-000045.Report this figure
Basic EPS$ per share(0.57)Basic EPS, Q3 FY2023, three months to 2023-09-30−$0.57 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2024-11-12, accession 0001759425-24-000038.Report this figurenot reported(0.54)Basic EPS, Q1 FY2024, three months to 2024-03-31−$0.54 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-05-07, accession 0001759425-25-000032.Report this figure(0.52)Basic EPS, Q2 FY2024, three months to 2024-06-30−$0.52 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-08-06, accession 0001759425-25-000041.Report this figure(0.30)Basic EPS, Q3 FY2024, three months to 2024-09-30−$0.30 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-04, accession 0001759425-25-000054.Report this figurenot reported(0.30)Basic EPS, Q1 FY2025, three months to 2025-03-31−$0.30 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-06, accession 0001759425-26-000037.Report this figure(0.12)Basic EPS, Q2 FY2025, three months to 2025-06-30−$0.12 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-05, accession 0001759425-26-000045.Report this figure0.06Basic EPS, Q3 FY2025, three months to 2025-09-30$0.06 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-04, accession 0001759425-25-000054.Report this figurenot reported(13.43)Basic EPS, Q1 FY2026, three months to 2026-03-31−$13.43 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-06, accession 0001759425-26-000037.Report this figure(1.06)Basic EPS, Q2 FY2026, three months to 2026-06-30−$1.06 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-05, accession 0001759425-26-000045.Report this figure

Balance sheet

Cash and equivalents$330.7m, Q2 FY2026
Shareholders' equity−$10.4m, Q2 FY2026
Mirum Pharmaceuticals, Inc., balance sheet, quarterly
Line itemUnitQ3 FY20232023-09-30FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Cash and equivalents$m303Cash and equivalents, Q3 FY2023, at 2023-09-30$303.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-11-12, accession 0001759425-24-000038.Report this figure286Cash and equivalents, FY2023, at 2023-12-31$286.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2025-02-26, accession 0001759425-25-000014.Report this figure303Cash and equivalents, Q1 FY2024, at 2024-03-31$302.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-05-07, accession 0001759425-25-000032.Report this figure233Cash and equivalents, Q2 FY2024, at 2024-06-30$233.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-08-06, accession 0001759425-25-000041.Report this figure223Cash and equivalents, Q3 FY2024, at 2024-09-30$223.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-04, accession 0001759425-25-000054.Report this figure223Cash and equivalents, FY2024, at 2024-12-31$222.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-02-25, accession 0001759425-26-000013.Report this figure212Cash and equivalents, Q1 FY2025, at 2025-03-31$211.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-06, accession 0001759425-26-000037.Report this figure228Cash and equivalents, Q2 FY2025, at 2025-06-30$228.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-05, accession 0001759425-26-000045.Report this figure282Cash and equivalents, Q3 FY2025, at 2025-09-30$282.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-04, accession 0001759425-25-000054.Report this figure297Cash and equivalents, FY2025, at 2025-12-31$296.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-05, accession 0001759425-26-000045.Report this figure325Cash and equivalents, Q1 FY2026, at 2026-03-31$324.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-06, accession 0001759425-26-000037.Report this figure331Cash and equivalents, Q2 FY2026, at 2026-06-30$330.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-05, accession 0001759425-26-000045.Report this figure
Current assets$m389Current assets, Q3 FY2023, at 2023-09-30$388.6m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2023-11-02, accession 0000950170-23-058228.Report this figure388Current assets, FY2023, at 2023-12-31$387.5m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2025-02-26, accession 0001759425-25-000014.Report this figure389Current assets, Q1 FY2024, at 2024-03-31$389.5m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-05-08, accession 0001759425-24-000019.Report this figure368Current assets, Q2 FY2024, at 2024-06-30$367.8m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-08-07, accession 0001759425-24-000031.Report this figure387Current assets, Q3 FY2024, at 2024-09-30$386.6m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-11-12, accession 0001759425-24-000038.Report this figure393Current assets, FY2024, at 2024-12-31$392.8m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-02-25, accession 0001759425-26-000013.Report this figure411Current assets, Q1 FY2025, at 2025-03-31$410.8m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-05-07, accession 0001759425-25-000032.Report this figure453Current assets, Q2 FY2025, at 2025-06-30$453.4m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-08-06, accession 0001759425-25-000041.Report this figure531Current assets, Q3 FY2025, at 2025-09-30$530.6m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-11-04, accession 0001759425-25-000054.Report this figure550Current assets, FY2025, at 2025-12-31$549.7m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-05, accession 0001759425-26-000045.Report this figure569Current assets, Q1 FY2026, at 2026-03-31$569.4m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-05-06, accession 0001759425-26-000037.Report this figure636Current assets, Q2 FY2026, at 2026-06-30$636.3m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-05, accession 0001759425-26-000045.Report this figure
Total assets$m651Total assets, Q3 FY2023, at 2023-09-30$650.6m. XBRL concept us-gaap:Assets. 10-Q filed 2023-11-02, accession 0000950170-23-058228.Report this figure647Total assets, FY2023, at 2023-12-31$646.6m. XBRL concept us-gaap:Assets. 10-K filed 2025-02-26, accession 0001759425-25-000014.Report this figure652Total assets, Q1 FY2024, at 2024-03-31$652.0m. XBRL concept us-gaap:Assets. 10-Q filed 2024-05-08, accession 0001759425-24-000019.Report this figure661Total assets, Q2 FY2024, at 2024-06-30$660.8m. XBRL concept us-gaap:Assets. 10-Q filed 2024-08-07, accession 0001759425-24-000031.Report this figure668Total assets, Q3 FY2024, at 2024-09-30$667.9m. XBRL concept us-gaap:Assets. 10-Q filed 2024-11-12, accession 0001759425-24-000038.Report this figure671Total assets, FY2024, at 2024-12-31$670.8m. XBRL concept us-gaap:Assets. 10-K filed 2026-02-25, accession 0001759425-26-000013.Report this figure690Total assets, Q1 FY2025, at 2025-03-31$690.2m. XBRL concept us-gaap:Assets. 10-Q filed 2025-05-07, accession 0001759425-25-000032.Report this figure726Total assets, Q2 FY2025, at 2025-06-30$725.8m. XBRL concept us-gaap:Assets. 10-Q filed 2025-08-06, accession 0001759425-25-000041.Report this figure785Total assets, Q3 FY2025, at 2025-09-30$785.1m. XBRL concept us-gaap:Assets. 10-Q filed 2025-11-04, accession 0001759425-25-000054.Report this figure843Total assets, FY2025, at 2025-12-31$842.8m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-05, accession 0001759425-26-000045.Report this figure891Total assets, Q1 FY2026, at 2026-03-31$890.9m. XBRL concept us-gaap:Assets. 10-Q filed 2026-05-06, accession 0001759425-26-000037.Report this figure1,045Total assets, Q2 FY2026, at 2026-06-30$1.04bn. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-05, accession 0001759425-26-000045.Report this figure
Current liabilities$m74.7Current liabilities, Q3 FY2023, at 2023-09-30$74.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2023-11-02, accession 0000950170-23-058228.Report this figure87.1Current liabilities, FY2023, at 2023-12-31$87.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2025-02-26, accession 0001759425-25-000014.Report this figure106Current liabilities, Q1 FY2024, at 2024-03-31$105.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-05-08, accession 0001759425-24-000019.Report this figure112Current liabilities, Q2 FY2024, at 2024-06-30$112.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-08-07, accession 0001759425-24-000031.Report this figure116Current liabilities, Q3 FY2024, at 2024-09-30$115.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-11-12, accession 0001759425-24-000038.Report this figure127Current liabilities, FY2024, at 2024-12-31$126.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-02-25, accession 0001759425-26-000013.Report this figure128Current liabilities, Q1 FY2025, at 2025-03-31$127.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-05-07, accession 0001759425-25-000032.Report this figure145Current liabilities, Q2 FY2025, at 2025-06-30$144.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-08-06, accession 0001759425-25-000041.Report this figure160Current liabilities, Q3 FY2025, at 2025-09-30$160.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-11-04, accession 0001759425-25-000054.Report this figure206Current liabilities, FY2025, at 2025-12-31$205.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-05, accession 0001759425-26-000045.Report this figure273Current liabilities, Q1 FY2026, at 2026-03-31$272.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-05-06, accession 0001759425-26-000037.Report this figure223Current liabilities, Q2 FY2026, at 2026-06-30$222.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-05, accession 0001759425-26-000045.Report this figure
Total liabilities$m382Total liabilities, Q3 FY2023, at 2023-09-30$381.6m. XBRL concept us-gaap:Liabilities. 10-Q filed 2023-11-02, accession 0000950170-23-058228.Report this figure398Total liabilities, FY2023, at 2023-12-31$398.0m. XBRL concept us-gaap:Liabilities. 10-K filed 2025-02-26, accession 0001759425-25-000014.Report this figure417Total liabilities, Q1 FY2024, at 2024-03-31$417.4m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-05-08, accession 0001759425-24-000019.Report this figure432Total liabilities, Q2 FY2024, at 2024-06-30$431.8m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-08-07, accession 0001759425-24-000031.Report this figure436Total liabilities, Q3 FY2024, at 2024-09-30$435.9m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-11-12, accession 0001759425-24-000038.Report this figure445Total liabilities, FY2024, at 2024-12-31$445.1m. XBRL concept us-gaap:Liabilities. 10-K filed 2026-02-25, accession 0001759425-26-000013.Report this figure457Total liabilities, Q1 FY2025, at 2025-03-31$457.0m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-05-07, accession 0001759425-25-000032.Report this figure471Total liabilities, Q2 FY2025, at 2025-06-30$470.7m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-08-06, accession 0001759425-25-000041.Report this figure493Total liabilities, Q3 FY2025, at 2025-09-30$493.1m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-11-04, accession 0001759425-25-000054.Report this figure528Total liabilities, FY2025, at 2025-12-31$528.1m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-05, accession 0001759425-26-000045.Report this figure648Total liabilities, Q1 FY2026, at 2026-03-31$648.4m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-05-06, accession 0001759425-26-000037.Report this figure1,055Total liabilities, Q2 FY2026, at 2026-06-30$1.06bn. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-05, accession 0001759425-26-000045.Report this figure
Shareholders' equity$m269Shareholders' equity, Q3 FY2023, at 2023-09-30$269.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-11-12, accession 0001759425-24-000038.Report this figure249Shareholders' equity, FY2023, at 2023-12-31$248.7m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-02-25, accession 0001759425-26-000013.Report this figure235Shareholders' equity, Q1 FY2024, at 2024-03-31$234.6m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-04, accession 0001759425-25-000054.Report this figure229Shareholders' equity, Q2 FY2024, at 2024-06-30$229.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-04, accession 0001759425-25-000054.Report this figure232Shareholders' equity, Q3 FY2024, at 2024-09-30$232.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-04, accession 0001759425-25-000054.Report this figure226Shareholders' equity, FY2024, at 2024-12-31$225.6m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-05, accession 0001759425-26-000045.Report this figure233Shareholders' equity, Q1 FY2025, at 2025-03-31$233.3m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-05, accession 0001759425-26-000045.Report this figure255Shareholders' equity, Q2 FY2025, at 2025-06-30$255.2m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-05, accession 0001759425-26-000045.Report this figure292Shareholders' equity, Q3 FY2025, at 2025-09-30$292.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-04, accession 0001759425-25-000054.Report this figure315Shareholders' equity, FY2025, at 2025-12-31$314.7m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-05, accession 0001759425-26-000045.Report this figure242Shareholders' equity, Q1 FY2026, at 2026-03-31$242.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-05, accession 0001759425-26-000045.Report this figure(10.4)Shareholders' equity, Q2 FY2026, at 2026-06-30−$10.4m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-05, accession 0001759425-26-000045.Report this figure

Cash flow

Operating cash flow−$44.3m, Q2 FY2026
Capital expenditure$23.0k, Q2 FY2026
Mirum Pharmaceuticals, Inc., cash flow, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Operating cash flow$m(18.2)Operating cash flow, Q3 FY2023, three months to 2023-09-30−$18.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2024-11-12, accession 0001759425-24-000038. Derived: 9-month figure less the 6-month figure.Report this figure(16.6)Operating cash flow, Q4 FY2023, three months to 2023-12-31−$16.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-25, accession 0001759425-26-000013. Derived: 12-month figure less the 9-month figure.Report this figure15.2Operating cash flow, Q1 FY2024, three months to 2024-03-31$15.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-05-07, accession 0001759425-25-000032.Report this figure(3.8)Operating cash flow, Q2 FY2024, three months to 2024-06-30−$3.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-08-06, accession 0001759425-25-000041. Derived: 6-month figure less the 3-month figure.Report this figure4.0Operating cash flow, Q3 FY2024, three months to 2024-09-30$4.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-04, accession 0001759425-25-000054. Derived: 9-month figure less the 6-month figure.Report this figure(5.1)Operating cash flow, Q4 FY2024, three months to 2024-12-31−$5.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-25, accession 0001759425-26-000013. Derived: 12-month figure less the 9-month figure.Report this figure(2.0)Operating cash flow, Q1 FY2025, three months to 2025-03-31−$2.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-06, accession 0001759425-26-000037.Report this figure12.0Operating cash flow, Q2 FY2025, three months to 2025-06-30$12.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-05, accession 0001759425-26-000045. Derived: 6-month figure less the 3-month figure.Report this figure39.7Operating cash flow, Q3 FY2025, three months to 2025-09-30$39.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-04, accession 0001759425-25-000054. Derived: 9-month figure less the 6-month figure.Report this figure6.1Operating cash flow, Q4 FY2025, three months to 2025-12-31$6.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-25, accession 0001759425-26-000013. Derived: 12-month figure less the 9-month figure.Report this figure(229)Operating cash flow, Q1 FY2026, three months to 2026-03-31−$228.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-06, accession 0001759425-26-000037.Report this figure(44.3)Operating cash flow, Q2 FY2026, three months to 2026-06-30−$44.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-05, accession 0001759425-26-000045. Derived: 6-month figure less the 3-month figure.Report this figure
Capital expenditure$m0.0Capital expenditure, Q3 FY2023, three months to 2023-09-30$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2024-11-12, accession 0001759425-24-000038. Derived: 9-month figure less the 6-month figure.Report this figure0.0Capital expenditure, Q4 FY2023, three months to 2023-12-31$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-25, accession 0001759425-26-000013. Derived: 12-month figure less the 9-month figure.Report this figure0.0Capital expenditure, Q1 FY2024, three months to 2024-03-31$13.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-05-07, accession 0001759425-25-000032.Report this figure0.8Capital expenditure, Q2 FY2024, three months to 2024-06-30$779.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-08-06, accession 0001759425-25-000041. Derived: 6-month figure less the 3-month figure.Report this figure0.2Capital expenditure, Q3 FY2024, three months to 2024-09-30$181.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-04, accession 0001759425-25-000054. Derived: 9-month figure less the 6-month figure.Report this figure0.0Capital expenditure, Q4 FY2024, three months to 2024-12-31$20.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-25, accession 0001759425-26-000013. Derived: 12-month figure less the 9-month figure.Report this figure0.0Capital expenditure, Q1 FY2025, three months to 2025-03-31$41.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-06, accession 0001759425-26-000037.Report this figure0.1Capital expenditure, Q2 FY2025, three months to 2025-06-30$126.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-05, accession 0001759425-26-000045. Derived: 6-month figure less the 3-month figure.Report this figure0.2Capital expenditure, Q3 FY2025, three months to 2025-09-30$187.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-04, accession 0001759425-25-000054. Derived: 9-month figure less the 6-month figure.Report this figure0.6Capital expenditure, Q4 FY2025, three months to 2025-12-31$600.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-25, accession 0001759425-26-000013. Derived: 12-month figure less the 9-month figure.Report this figure0.7Capital expenditure, Q1 FY2026, three months to 2026-03-31$664.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-06, accession 0001759425-26-000037.Report this figure0.0Capital expenditure, Q2 FY2026, three months to 2026-06-30$23.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-05, accession 0001759425-26-000045. Derived: 6-month figure less the 3-month figure.Report this figure

Shares

Diluted shares (weighted)63.37m, Q2 FY2026
Mirum Pharmaceuticals, Inc., shares, quarterly
Line itemUnitQ3 FY20222022-09-30Q1 FY20232023-03-31Q2 FY20232023-06-30Q3 FY20232023-09-30Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q1 FY20262026-03-31Q2 FY20262026-06-30
Diluted shares (weighted)m shares34.9Diluted shares (weighted), Q3 FY2022, three months to 2022-09-3034,927,790 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2023-11-02, accession 0000950170-23-058228.Report this figure37.7Diluted shares (weighted), Q1 FY2023, three months to 2023-03-3137,675,306 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-05-08, accession 0001759425-24-000019.Report this figure38.1Diluted shares (weighted), Q2 FY2023, three months to 2023-06-3038,107,334 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-08-07, accession 0001759425-24-000031.Report this figure41.1Diluted shares (weighted), Q3 FY2023, three months to 2023-09-3041,098,920 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-11-12, accession 0001759425-24-000038.Report this figure46.9Diluted shares (weighted), Q1 FY2024, three months to 2024-03-3146,927,550 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-05-07, accession 0001759425-25-000032.Report this figure47.2Diluted shares (weighted), Q2 FY2024, three months to 2024-06-3047,235,080 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-08-06, accession 0001759425-25-000041.Report this figure47.8Diluted shares (weighted), Q3 FY2024, three months to 2024-09-3047,782,619 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-04, accession 0001759425-25-000054.Report this figure48.9Diluted shares (weighted), Q1 FY2025, three months to 2025-03-3148,889,058 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-06, accession 0001759425-26-000037.Report this figure49.7Diluted shares (weighted), Q2 FY2025, three months to 2025-06-3049,726,823 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-05, accession 0001759425-26-000045.Report this figure57.0Diluted shares (weighted), Q3 FY2025, three months to 2025-09-3056,993,841 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-04, accession 0001759425-25-000054.Report this figure58.9Diluted shares (weighted), Q1 FY2026, three months to 2026-03-3158,851,021 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-06, accession 0001759425-26-000037.Report this figure63.4Diluted shares (weighted), Q2 FY2026, three months to 2026-06-3063,374,183 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-05, accession 0001759425-26-000045.Report this figure

Shares outstanding: 64.93mShares outstanding, period not labelled, at 2026-07-3164,932,203 shares. XBRL concept dei:EntityCommonStockSharesOutstanding. 10-Q filed 2026-08-05, accession 0001759425-26-000045.Report this figure at Jul 31, 2026, from the cover of the 10-Q filed Aug 5, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:47 ET. Listed shows no prices and gives no investment advice.